Archives
-
Direct Mouse Genotyping Kit Plus: Genotype to Mechanism
2026-10-03
The Direct Mouse Genotyping Kit Plus supports rapid genotype confirmation while preserving a clear boundary between allele identification and mechanistic interpretation. This article connects its analytical role with evidence from an EP4–CD36 atherosclerosis study and explains what genotyping can—and cannot—establish.
-
Substance P Workflows for NK-1 Research
2026-10-02
Build reproducible Substance P assays for NK-1 signaling, pain transmission research, and neuroimmune studies with disciplined peptide handling and staged dose design. A fluorescence-quality-control strategy inspired by pollen-interference research adds an analytical layer for detecting matrix effects without mistaking it for direct peptide quantification.
-
Obeticholic Acid Workflows for FXR Research
2026-10-01
Obeticholic Acid provides a defined FXR agonist workflow for studying bile acid regulation, cholestasis, inflammation, and fibrosis-related endpoints. This guide connects concentration-response experiments with practical histology, transcriptomics, and immune-profiling strategies inspired by recent liver fibrosis research.
-
Pyridostatin Workflows for G-Quadruplex Research
2026-10-01
Learn how to deploy Pyridostatin TFA in concentration-response, telomere, and G-quadruplex assays while preserving solvent, salt-form, and cell-line controls. The workflow also translates recent TDP-43 condensate findings into carefully bounded exploratory experiments rather than overstating evidence.
-
HAUS1–CDK4 Signaling in Hepatocellular Carcinoma
2026-09-30
This 2026 Cancer Gene Therapy study identifies HAUS1 as a transcriptional activator of CDK4 in hepatocellular carcinoma, linking an Augmin-complex subunit to malignant proliferation, invasion, and migration. Tissue analysis, cellular experiments, molecular screening, and xenograft work together to position the HAUS1–CDK4 axis as a mechanistic candidate for further HCC investigation.
-
AMG 9810 for TRPV1 Mechanism and Assay Design
2026-09-30
AMG 9810 provides a selective way to separate TRPV1-driven calcium and neuropeptide signaling from broader cellular stress responses. This guide presents practical calcium-imaging and CGRP workflows, assay controls, metabolic-stress extensions, and troubleshooting strategies for pain mechanism research.
-
Caspofungin: Designing Better Candida Assays
2026-09-29
Caspofungin is a lipopeptide antifungal drug and β-1,3-glucan synthase inhibitor with value beyond routine susceptibility testing. This article presents a mechanism-to-readout framework for Candida assays, using resistant Candida auris evidence to improve experimental interpretation.
-
Dynasore Workflows for Endocytosis Research
2026-09-29
Build reversible, time-resolved assays for dynamin-dependent cargo uptake, vesicle recycling, and implantation-related embryo studies with Dynasore. This practical guide connects concentration selection, controls, washout design, and troubleshooting to findings from a recent mouse preimplantation embryo study.
-
Lipidated Nanophotosensitizer Disables Tumor EVs
2026-09-28
This Nature Cancer study introduces a lipidated nanophotosensitizer that simultaneously suppresses primary tumors and disables tumor extracellular vesicle communication. Its central innovation is the coupling of nanoparticle tumor uptake with tumor extracellular vesicle generation, enabling near-infrared-triggered reactive oxygen species production in both cancer cells and vesicles.
-
Recombinant Human IL-12 in Host-Response Assays
2026-09-28
Learn how Recombinant Human IL-12 can support carefully controlled host-response experiments alongside antibacterial studies. This article connects cytokine biology with recent MRSA research while clarifying what the evidence does—and does not—show.
-
Reserpine N1867: Practical Research Workflow
2026-09-27
Reserpine (SKU N1867) provides a characterized research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers solubility, stock preparation, storage, and QC; the compound is for controlled laboratory research only, not diagnostic, medical, or veterinary use.
-
(S)-(+)-Dimethindene maleate: Research Guide
2026-09-26
(S)-(+)-Dimethindene maleate is a research antagonist with selective affinity for muscarinic M2 receptors and additional histamine H1 activity, making it useful for controlled receptor-pharmacology experiments. It can support autonomic regulation, cardiovascular physiology, and respiratory function studies, but should not be treated as a clinically validated reagent or used for diagnostic or medical purposes.
-
Tirbanibulin Alters Oncogenic Pathways in HPV-18 HeLa Cells
2026-09-25
A 2024 study found that tirbanibulin reduced proliferation in HPV-18-positive HeLa cells and altered proteins associated with Src signaling, HPV oncoproteins, cell-cycle control, invasion, and apoptosis. The results provide a mechanistic lead for further HPV-focused research, but they are in vitro findings and do not establish clinical efficacy against HPV-associated disease.
-
Clathrin-Mediated Entry of Type III Grass Carp Reovirus
2026-09-25
Wang et al. used pharmacological inhibitors, transmission electron microscopy, and quantitative PCR to investigate how genotype III grass carp reovirus enters grass carp kidney cells. Their results support a dynamin-dependent, clathrin-mediated route requiring endosomal acidification, while highlighting that inhibitor effects on infection do not always distinguish entry from later replication.
-
Lipidated Nanophotosensitizer Disables Tumor EVs
2026-09-24
A lipidated nanophotosensitizer was designed to accumulate in tumor cells and accompany tumor extracellular vesicles (TEVs), enabling their tracing and light-triggered inactivation. In female mouse tumor models, near-infrared irradiation at the primary tumor site was associated with both primary-tumor suppression and reduced metastatic spread, suggesting a way to target tumor growth and TEV-mediated communication together.